NewsRx

Search our medical news database

Blood Products

BPAC recommends COBAS AmpliScreen HBV Test for donated blood

Published in Blood Weekly, September 9th, 2004

Roche Diagnostics announced that the Blood Products Advisory Committee (BPAC) of the United States Food and Drug Administration (FDA) voted overwhelmingly that the sensitivity and specificity of Roche's COBAS AmpliScreen HBV Test in a minipool format supported licensing as a screening test for the detection of hepatitis B (HBV) in donated whole blood.

The advisory committee's 15-1 vote supporting licensure was made July 24, 2004, after Roche Molecular Systems (RMS) presented results from their clinical study at a meeting of the BPAC. The test is the first nucleic acid test designed for screening whole blood for HBV to be accepted for review by the FDA.

...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Blood Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook